APAC Life Sciences and Health Care Webinar Series - Spotlight on Greater China

Companies in the life sciences and health care industry continue to navigate unparalleled challenges during the COVID-19 pandemic while also seeking to balance commercial opportunities and evolving risks.

Over the past decade, China’s life sciences and health care sector has experienced unprecedented growth. China presents real opportunities for life sciences and health care companies, but knowing the evolving laws, regulations, rules and relevant guidance, and being able to navigate them successfully, require deep insights and experience. Keeping up with the rapid pace of change in the regulatory landscape can be challenging.

Join the Hogan Lovells APAC Life Sciences and Health Care team for a five-part webinar series in which they discussed the trends and challenges that companies in the life sciences and health care industry may be facing when planning or conducting business in Greater China:

Session 1

Internal investigations and enforcement trends in the Life Sciences sector in China

Session 2

China’s data protection regime and risk management for the handling of human genetic resources under relevant regulations in China

Session 3

Out-licensing to Chinese counterparties, including related necessary IP protections

Session 4

Life Sciences companies navigating the shifting patent landscape in China

Session 5

How to navigate antitrust and regulatory risks in life sciences distribution channels in Greater China

If you’d like to receive the materials and recordings of this webinar series, please contact Cheryl Yang.

Back To Listing